APO Research
Talk to an analyst

APO RESEARCH · REPORT

5-Hydroxytryptamine

5-Hydroxytryptamine refers to medicinal, supplement or research preparations identified by the named composition or biological target.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.

What turns activity into demand

Distinguish equipment procurement, recurring materials and any related service within the selected study. Research use, educational use and clinical use have different acceptance requirements and should not be treated as one demand measure.

The commercial boundary

Separate research materials, devices and services within the selected edition. Approvals, labelled use and clinical acceptance need their own evidence; no medical suitability follows from this illustration.

Which supplied scope and interfaces define 5-Hydroxytryptamine?

Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.

Selected research

Market Structure

Global 5-Hydroxytryptamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025191 pages

Choose your research edition.

Industry Research5-Hydroxytryptamine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal 5-Hydroxytryptamine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal 5-Hydroxytryptamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 5-Hydroxytryptamine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal 5-Hydroxytryptamine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global 5-Hydroxytryptamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for 5-Hydroxytryptamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 5-Hydroxytryptamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 5-Hydroxytryptamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 5-Hydroxytryptamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 5-Hydroxytryptamine include Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals and Suven Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global 5-Hydroxytryptamine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 5-Hydroxytryptamine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 5-Hydroxytryptamine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the 5-Hydroxytryptamine market size, projected growth trends, production technologies, key applications, and end-use industries.

5-Hydroxytryptamine Segment by Company

Adamed

Avineuro Pharmaceutical

Axovant Sciences

Biotie Therapies

Celon Pharma

Galenea Corp

H. Lundbeck

Reviva Pharmaceuticals

Suven Life Sciences

Teva Pharmaceutical Industries Ltd

5-Hydroxytryptamine Segment by Type

HTR6

HTR2B

Others

5-Hydroxytryptamine Segment by Application

Alzheimer's Disease

Memory Impairment

Psychiatric Disorders

Chronic Obstructive Pulmonary Disease

Attention Deficit Hyperactivity Disorder

5-Hydroxytryptamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 5-Hydroxytryptamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 5-Hydroxytryptamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 5-Hydroxytryptamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of 5-Hydroxytryptamine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 5-Hydroxytryptamine industry.

Chapter 3: Detailed analysis of 5-Hydroxytryptamine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 5-Hydroxytryptaminerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global 5-Hydroxytryptamine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of HTR6 Table 3. Key Players of HTR2B Table 4. Key Players of Others Table 4. Global 5-Hydroxytryptamine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Alzheimer's Disease Table 6. Key Players of Memory Impairment Table 7. Key Players of Psychiatric Disorders Table 8. Key Players of Chronic Obstructive Pulmonary Disease Table 9. Key Players of Attention Deficit Hyperactivity Disorder Table 10. Global 5-Hydroxytryptamine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global 5-Hydroxytryptamine Market Size by Region (2021-2026) & (US$ Million) Table 12. Global 5-Hydroxytryptamine Market Share by Region (2021-2026) Table 13. Global 5-Hydroxytryptamine Market Size by Region (2027-2032) & (US$ Million) Table 14. Global 5-Hydroxytryptamine Market Share by Region (2027-2032) Table 15. 5-Hydroxytryptamine Industry Trends Table 16. 5-Hydroxytryptamine Industry Drivers Table 17. 5-Hydroxytryptamine Industry Opportunities and Challenges Table 18. 5-Hydroxytryptamine Industry Restraints Table 19. Global 5-Hydroxytryptamine Revenue by Company (US$ Million) & (2021-2026) Table 20. Global 5-Hydroxytryptamine Revenue Market Share by Company (2021-2026) Table 21. Global 5-Hydroxytryptamine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global 5-Hydroxytryptamine Key Company Head Office and Area Served Table 23. Global 5-Hydroxytryptamine Company, Product Type & Application Table 24. Global 5-Hydroxytryptamine Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global 5-Hydroxytryptamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global 5-Hydroxytryptamine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global 5-Hydroxytryptamine Market Size by Type (2021-2026) & (US$ Million) Table 29. Global 5-Hydroxytryptamine Market Size by Type (2027-2032) & (US$ Million) Table 30. Global 5-Hydroxytryptamine Revenue Market Share by Type (2021-2026) Table 31. Global 5-Hydroxytryptamine Revenue Market Share by Type (2027-2032) Table 32. Global 5-Hydroxytryptamine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global 5-Hydroxytryptamine Market Size by Application (2021-2026) & (US$ Million) Table 34. Global 5-Hydroxytryptamine Market Size by Application (2027-2032) & (US$ Million) Table 35. Global 5-Hydroxytryptamine Revenue Market Share by Application (2021-2026) Table 36. Global 5-Hydroxytryptamine Revenue Market Share by Application (2027-2032) Table 37. Adamed Company Information Table 38. Adamed Business Overview Table 39. Adamed 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Adamed 5-Hydroxytryptamine Product Portfolio Table 41. Adamed Recent Development Table 42. Avineuro Pharmaceutical Company Information Table 43. Avineuro Pharmaceutical Business Overview Table 44. Avineuro Pharmaceutical 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Avineuro Pharmaceutical 5-Hydroxytryptamine Product Portfolio Table 46. Avineuro Pharmaceutical Recent Development Table 47. Axovant Sciences Company Information Table 48. Axovant Sciences Business Overview Table 49. Axovant Sciences 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Axovant Sciences 5-Hydroxytryptamine Product Portfolio Table 51. Axovant Sciences Recent Development Table 52. Biotie Therapies Company Information Table 53. Biotie Therapies Business Overview Table 54. Biotie Therapies 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Biotie Therapies 5-Hydroxytryptamine Product Portfolio Table 56. Biotie Therapies Recent Development Table 57. Celon Pharma Company Information Table 58. Celon Pharma Business Overview Table 59. Celon Pharma 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Celon Pharma 5-Hydroxytryptamine Product Portfolio Table 61. Celon Pharma Recent Development Table 62. Galenea Corp Company Information Table 63. Galenea Corp Business Overview Table 64. Galenea Corp 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Galenea Corp 5-Hydroxytryptamine Product Portfolio Table 66. Galenea Corp Recent Development Table 67. H. Lundbeck Company Information Table 68. H. Lundbeck Business Overview Table 69. H. Lundbeck 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. H. Lundbeck 5-Hydroxytryptamine Product Portfolio Table 71. H. Lundbeck Recent Development Table 72. Reviva Pharmaceuticals Company Information Table 73. Reviva Pharmaceuticals Business Overview Table 74. Reviva Pharmaceuticals 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Reviva Pharmaceuticals 5-Hydroxytryptamine Product Portfolio Table 76. Reviva Pharmaceuticals Recent Development Table 77. Suven Life Sciences Company Information Table 78. Suven Life Sciences Business Overview Table 79. Suven Life Sciences 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Suven Life Sciences 5-Hydroxytryptamine Product Portfolio Table 81. Suven Life Sciences Recent Development Table 82. Teva Pharmaceutical Industries Ltd Company Information Table 83. Teva Pharmaceutical Industries Ltd Business Overview Table 84. Teva Pharmaceutical Industries Ltd 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Teva Pharmaceutical Industries Ltd 5-Hydroxytryptamine Product Portfolio Table 86. Teva Pharmaceutical Industries Ltd Recent Development Table 87. North America 5-Hydroxytryptamine Market Size by Type (2021-2026) & (US$ Million) Table 88. North America 5-Hydroxytryptamine Market Size by Type (2027-2032) & (US$ Million) Table 89. North America 5-Hydroxytryptamine Market Size by Application (2021-2026) & (US$ Million) Table 90. North America 5-Hydroxytryptamine Market Size by Application (2027-2032) & (US$ Million) Table 91. North America 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America 5-Hydroxytryptamine Market Size by Country (2021-2026) Table 93. North America 5-Hydroxytryptamine Market Size by Country (2027-2032) Table 94. Europe 5-Hydroxytryptamine Market Size by Type (2021-2026) & (US$ Million) Table 95. Europe 5-Hydroxytryptamine Market Size by Type (2027-2032) & (US$ Million) Table 96. Europe 5-Hydroxytryptamine Market Size by Application (2021-2026) & (US$ Million) Table 97. Europe 5-Hydroxytryptamine Market Size by Application (2027-2032) & (US$ Million) Table 98. Europe 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe 5-Hydroxytryptamine Market Size by Country (2021-2026) Table 100. Europe 5-Hydroxytryptamine Market Size by Country (2027-2032) Table 101. China 5-Hydroxytryptamine Market Size by Type (2021-2026) & (US$ Million) Table 102. China 5-Hydroxytryptamine Market Size by Type (2027-2032) & (US$ Million) Table 103. China 5-Hydroxytryptamine Market Size by Application (2021-2026) & (US$ Million) Table 104. China 5-Hydroxytryptamine Market Size by Application (2027-2032) & (US$ Million) Table 105. Asia 5-Hydroxytryptamine Market Size by Type (2021-2026) & (US$ Million) Table 106. Asia 5-Hydroxytryptamine Market Size by Type (2027-2032) & (US$ Million) Table 107. Asia 5-Hydroxytryptamine Market Size by Application (2021-2026) & (US$ Million) Table 108. Asia 5-Hydroxytryptamine Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia 5-Hydroxytryptamine Market Size by Country (2021-2026) Table 111. Asia 5-Hydroxytryptamine Market Size by Country (2027-2032) Table 112. South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Type (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Type (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Application (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Application (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Country (2021-2026) Table 118. South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Country (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. 5-Hydroxytryptamine Product Image Figure 2. Global 5-Hydroxytryptamine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global 5-Hydroxytryptamine Market Share by Type: 2025 VS 2032 Figure 4. HTR6 Image Figure 5. HTR2B Image Figure 6. Others Image Figure 7. Global 5-Hydroxytryptamine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global 5-Hydroxytryptamine Market Share by Application: 2025 VS 2032 Figure 9. Alzheimer's Disease Image Figure 10. Memory Impairment Image Figure 11. Psychiatric Disorders Image Figure 12. Chronic Obstructive Pulmonary Disease Image Figure 13. Attention Deficit Hyperactivity Disorder Image Figure 14. Global 5-Hydroxytryptamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 16. Global 5-Hydroxytryptamine Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global 5-Hydroxytryptamine Market Share by Players in 2025 Figure 19. Global Top 5 and 10 5-Hydroxytryptamine Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global 5-Hydroxytryptamine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global 5-Hydroxytryptamine Revenue Market Share by Type (2021-2032) Figure 23. Global 5-Hydroxytryptamine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global 5-Hydroxytryptamine Revenue Market Share by Application (2021-2032) Figure 25. North America 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 26. North America 5-Hydroxytryptamine Market Share by Type (2021-2032) Figure 27. North America 5-Hydroxytryptamine Market Share by Application (2021-2032) Figure 28. North America 5-Hydroxytryptamine Market Share by Country (2021-2032) Figure 29. United States 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 30. Canada 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 31. Mexico 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 32. Europe 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 33. Europe 5-Hydroxytryptamine Market Share by Type (2021-2032) Figure 34. Europe 5-Hydroxytryptamine Market Share by Application (2021-2032) Figure 35. Europe 5-Hydroxytryptamine Market Share by Country (2021-2032) Figure 36. Germany 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 37. France 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 38. U.K. 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 39. Italy 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 40. Russia 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 42. China 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 43. China 5-Hydroxytryptamine Market Share by Type (2021-2032) Figure 44. China 5-Hydroxytryptamine Market Share by Application (2021-2032) Figure 45. Asia 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 46. Asia 5-Hydroxytryptamine Market Share by Type (2021-2032) Figure 47. Asia 5-Hydroxytryptamine Market Share by Application (2021-2032) Figure 48. Asia 5-Hydroxytryptamine Market Share by Country (2021-2032) Figure 49. Japan 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 50. South Korea 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 53. India 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 54. Australia 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa 5-Hydroxytryptamine Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa 5-Hydroxytryptamine Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa 5-Hydroxytryptamine Market Share by Country (2021-2032) Figure 59. Brazil 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 60. South Africa 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 62. Turkey 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 63. Argentina 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 64. UAE 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 65. Egypt 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 66. Chile 5-Hydroxytryptamine Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • HTR6
  • HTR2B
  • Others
Applications
  • Alzheimer's Disease
  • Memory Impairment
  • Psychiatric Disorders
  • Chronic Obstructive Pulmonary Disease
  • Attention Deficit Hyperactivity Disorder
Companies covered
  • Adamed
  • Avineuro Pharmaceutical
  • Axovant Sciences
  • Biotie Therapies
  • Celon Pharma
  • Galenea Corp
  • H. Lundbeck
  • Reviva Pharmaceuticals
  • Suven Life Sciences
  • Teva Pharmaceutical Industries Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global 5-Hydroxytryptamine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 HTR6
  5. 1.2.3 HTR2B
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global 5-Hydroxytryptamine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Alzheimer's Disease
  10. 1.3.3 Memory Impairment
  11. 1.3.4 Psychiatric Disorders
  12. 1.3.5 Chronic Obstructive Pulmonary Disease
  13. 1.3.6 Attention Deficit Hyperactivity Disorder
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global 5-Hydroxytryptamine Growth Trends by Region
  16. 1.5.1 Global 5-Hydroxytryptamine Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 5-Hydroxytryptamine Market Size by Region (2021-2026)
  18. 1.5.3 5-Hydroxytryptamine Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global 5-Hydroxytryptamine Market Dynamics
  1. 2.1 5-Hydroxytryptamine Industry Trends
  2. 2.2 5-Hydroxytryptamine Industry Drivers
  3. 2.3 5-Hydroxytryptamine Industry Opportunities and Challenges
  4. 2.4 5-Hydroxytryptamine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global 5-Hydroxytryptamine Revenue by Company (2021-2026)
  2. 3.2 Global 5-Hydroxytryptamine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global 5-Hydroxytryptamine Key Company Head office and Area Served
  4. 3.4 Global 5-Hydroxytryptamine Company, Product Type & Application
  5. 3.5 Global 5-Hydroxytryptamine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global 5-Hydroxytryptamine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 5-Hydroxytryptamine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 5-Hydroxytryptamine Tier 1, Tier 2, and Tier 3
4 5-Hydroxytryptamine Market by Type
  1. 4.1 Global 5-Hydroxytryptamine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global 5-Hydroxytryptamine Market Size by Type (2021-2032)
  3. 4.3 Global 5-Hydroxytryptamine Market Size Share by Type (2021-2032)
5 5-Hydroxytryptamine Market by Application
  1. 5.1 Global 5-Hydroxytryptamine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global 5-Hydroxytryptamine Market Size by Application (2021-2032)
  3. 5.3 Global 5-Hydroxytryptamine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Adamed
  2. 6.1.1 Adamed Company Information
  3. 6.1.2 Adamed Business Overview
  4. 6.1.3 Adamed 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Adamed 5-Hydroxytryptamine Product Portfolio
  6. 6.1.5 Adamed Recent Developments
  7. 6.2 Avineuro Pharmaceutical
  8. 6.2.1 Avineuro Pharmaceutical Company Information
  9. 6.2.2 Avineuro Pharmaceutical Business Overview
  10. 6.2.3 Avineuro Pharmaceutical 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Avineuro Pharmaceutical 5-Hydroxytryptamine Product Portfolio
  12. 6.2.5 Avineuro Pharmaceutical Recent Developments
  13. 6.3 Axovant Sciences
  14. 6.3.1 Axovant Sciences Company Information
  15. 6.3.2 Axovant Sciences Business Overview
  16. 6.3.3 Axovant Sciences 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Axovant Sciences 5-Hydroxytryptamine Product Portfolio
  18. 6.3.5 Axovant Sciences Recent Developments
  19. 6.4 Biotie Therapies
  20. 6.4.1 Biotie Therapies Company Information
  21. 6.4.2 Biotie Therapies Business Overview
  22. 6.4.3 Biotie Therapies 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Biotie Therapies 5-Hydroxytryptamine Product Portfolio
  24. 6.4.5 Biotie Therapies Recent Developments
  25. 6.5 Celon Pharma
  26. 6.5.1 Celon Pharma Company Information
  27. 6.5.2 Celon Pharma Business Overview
  28. 6.5.3 Celon Pharma 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Celon Pharma 5-Hydroxytryptamine Product Portfolio
  30. 6.5.5 Celon Pharma Recent Developments
  31. 6.6 Galenea Corp
  32. 6.6.1 Galenea Corp Company Information
  33. 6.6.2 Galenea Corp Business Overview
  34. 6.6.3 Galenea Corp 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Galenea Corp 5-Hydroxytryptamine Product Portfolio
  36. 6.6.5 Galenea Corp Recent Developments
  37. 6.7 H. Lundbeck
  38. 6.7.1 H. Lundbeck Company Information
  39. 6.7.2 H. Lundbeck Business Overview
  40. 6.7.3 H. Lundbeck 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 H. Lundbeck 5-Hydroxytryptamine Product Portfolio
  42. 6.7.5 H. Lundbeck Recent Developments
  43. 6.8 Reviva Pharmaceuticals
  44. 6.8.1 Reviva Pharmaceuticals Company Information
  45. 6.8.2 Reviva Pharmaceuticals Business Overview
  46. 6.8.3 Reviva Pharmaceuticals 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Reviva Pharmaceuticals 5-Hydroxytryptamine Product Portfolio
  48. 6.8.5 Reviva Pharmaceuticals Recent Developments
  49. 6.9 Suven Life Sciences
  50. 6.9.1 Suven Life Sciences Company Information
  51. 6.9.2 Suven Life Sciences Business Overview
  52. 6.9.3 Suven Life Sciences 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Suven Life Sciences 5-Hydroxytryptamine Product Portfolio
  54. 6.9.5 Suven Life Sciences Recent Developments
  55. 6.10 Teva Pharmaceutical Industries Ltd
  56. 6.10.1 Teva Pharmaceutical Industries Ltd Company Information
  57. 6.10.2 Teva Pharmaceutical Industries Ltd Business Overview
  58. 6.10.3 Teva Pharmaceutical Industries Ltd 5-Hydroxytryptamine Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Industries Ltd 5-Hydroxytryptamine Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Industries Ltd Recent Developments
7 North America
  1. 7.1 North America 5-Hydroxytryptamine Market Size (2021-2032)
  2. 7.2 North America 5-Hydroxytryptamine Market Size by Type
  3. 7.2.1 North America 5-Hydroxytryptamine Market Size by Type (2021-2026)
  4. 7.2.2 North America 5-Hydroxytryptamine Market Size by Type (2027-2032)
  5. 7.2.3 North America 5-Hydroxytryptamine Market Share by Type (2021-2032)
  6. 7.3 North America 5-Hydroxytryptamine Market Size by Application
  7. 7.3.1 North America 5-Hydroxytryptamine Market Size by Application (2021-2026)
  8. 7.3.2 North America 5-Hydroxytryptamine Market Size by Application (2027-2032)
  9. 7.3.3 North America 5-Hydroxytryptamine Market Share by Application (2021-2032)
  10. 7.4 North America 5-Hydroxytryptamine Market Size by Country
  11. 7.4.1 North America 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America 5-Hydroxytryptamine Market Size by Country (2021-2026)
  13. 7.4.3 North America 5-Hydroxytryptamine Market Size by Country (2027-2032)
  14. 7.4.4 North America 5-Hydroxytryptamine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe 5-Hydroxytryptamine Market Size (2021-2032)
  2. 8.2 Europe 5-Hydroxytryptamine Market Size by Type
  3. 8.2.1 Europe 5-Hydroxytryptamine Market Size by Type (2021-2026)
  4. 8.2.2 Europe 5-Hydroxytryptamine Market Size by Type (2027-2032)
  5. 8.2.3 Europe 5-Hydroxytryptamine Market Share by Type (2021-2032)
  6. 8.3 Europe 5-Hydroxytryptamine Market Size by Application
  7. 8.3.1 Europe 5-Hydroxytryptamine Market Size by Application (2021-2026)
  8. 8.3.2 Europe 5-Hydroxytryptamine Market Size by Application (2027-2032)
  9. 8.3.3 Europe 5-Hydroxytryptamine Market Share by Application (2021-2032)
  10. 8.4 Europe 5-Hydroxytryptamine Market Size by Country
  11. 8.4.1 Europe 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe 5-Hydroxytryptamine Market Size by Country (2021-2026)
  13. 8.4.3 Europe 5-Hydroxytryptamine Market Size by Country (2027-2032)
  14. 8.4.4 Europe 5-Hydroxytryptamine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China 5-Hydroxytryptamine Market Size (2021-2032)
  2. 9.2 China 5-Hydroxytryptamine Market Size by Type
  3. 9.2.1 China 5-Hydroxytryptamine Market Size by Type (2021-2026)
  4. 9.2.2 China 5-Hydroxytryptamine Market Size by Type (2027-2032)
  5. 9.2.3 China 5-Hydroxytryptamine Market Share by Type (2021-2032)
  6. 9.3 China 5-Hydroxytryptamine Market Size by Application
  7. 9.3.1 China 5-Hydroxytryptamine Market Size by Application (2021-2026)
  8. 9.3.2 China 5-Hydroxytryptamine Market Size by Application (2027-2032)
  9. 9.3.3 China 5-Hydroxytryptamine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia 5-Hydroxytryptamine Market Size (2021-2032)
  2. 10.2 Asia 5-Hydroxytryptamine Market Size by Type
  3. 10.2.1 Asia 5-Hydroxytryptamine Market Size by Type (2021-2026)
  4. 10.2.2 Asia 5-Hydroxytryptamine Market Size by Type (2027-2032)
  5. 10.2.3 Asia 5-Hydroxytryptamine Market Share by Type (2021-2032)
  6. 10.3 Asia 5-Hydroxytryptamine Market Size by Application
  7. 10.3.1 Asia 5-Hydroxytryptamine Market Size by Application (2021-2026)
  8. 10.3.2 Asia 5-Hydroxytryptamine Market Size by Application (2027-2032)
  9. 10.3.3 Asia 5-Hydroxytryptamine Market Share by Application (2021-2032)
  10. 10.4 Asia 5-Hydroxytryptamine Market Size by Country
  11. 10.4.1 Asia 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia 5-Hydroxytryptamine Market Size by Country (2021-2026)
  13. 10.4.3 Asia 5-Hydroxytryptamine Market Size by Country (2027-2032)
  14. 10.4.4 Asia 5-Hydroxytryptamine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa 5-Hydroxytryptamine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa 5-Hydroxytryptamine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa 5-Hydroxytryptamine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa 5-Hydroxytryptamine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa 5-Hydroxytryptamine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst